|
Real-time Estimate
Tradegate
08:39:05 18/09/26 pm AEST
|
5-day change | 1st Jan Change | ||
| 58.38 EUR | -0.13% |
|
+1.83% | -7.66% |
| 23/07 | Laboratorios Farmaceuticos Rovi, S.A., H1 2026 Earnings Call, Jul 23, 2026 | |
| 23/07 | Laboratorios Farmaceuticos Rovi, S.A. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +1.28% | +2.62% | -2.60% | +3.64% | +7.24% | +51.61% | +100.19% | +400.84% | +1,362.49% | 1,027B | |
| +1.10% | +1.45% | +2.99% | +15.38% | +30.57% | +52.49% | +67.37% | +64.02% | +128.52% | 651B | |
| +0.58% | +3.54% | +5.47% | +19.34% | +15.55% | +19.57% | +73.56% | +145.08% | +317.29% | 467B | |
| +0.90% | +5.78% | +0.89% | +14.14% | +10.94% | +39.24% | +41.15% | +6.62% | +50.14% | 350B | |
| +0.62% | +4.12% | -7.09% | -1.17% | +6.44% | +20.64% | +26.78% | +51.09% | +48.42% | 268B | |
| +1.21% | +7.24% | +6.35% | -4.55% | -8.95% | +11.63% | +17.04% | +46.70% | +147.21% | 257B | |
| +0.91% | -0.70% | -9.44% | +11.16% | +16.03% | +38.25% | +45.67% | +73.12% | +119.58% | 205B | |
| +1.62% | +2.64% | -4.25% | +1.30% | -12.76% | -27.71% | -56.37% | -10.55% | +83.78% | 190B | |
| +2.17% | +4.20% | +8.62% | +20.28% | +22.93% | +34.41% | +99.41% | +110.71% | +91.48% | 187B | |
| +0.66% | -0.04% | +2.87% | +6.64% | +11.00% | +14.93% | -18.87% | -37.02% | -18.56% | 158B | |
| +0.60% | +0.35% | +0.15% | +12.49% | +13.89% | +33.37% | +47.99% | +174.21% | +456.94% | 131B | |
| -1.19% | -1.43% | -2.77% | +13.68% | +16.50% | +36.16% | +6.45% | +2.50% | +13.02% | 128B | |
| -0.16% | +2.57% | -3.26% | +2.45% | -9.16% | -6.25% | -26.10% | -8.38% | +7.91% | 104B | |
| -0.71% | +6.35% | -0.26% | -2.08% | +3.21% | +27.83% | +25.08% | +7.29% | -8.45% | 102B | |
| +0.93% | +5.05% | -1.48% | -10.84% | -18.16% | -0.33% | +51.32% | +63.38% | +480.72% | 70.58B | |
| +0.37% | +5.33% | +4.67% | +18.48% | +23.43% | +34.11% | +23.59% | +58.77% | +28.51% | 60.94B | |
| -0.97% | +0.85% | -0.33% | +30.77% | +31.26% | +76.33% | -0.13% | +7.31% | -46.97% | 55.31B | |
| +1.71% | +5.92% | +5.92% | +29.17% | +36.98% | +173.67% | +282.34% | +325.05% | -23.75% | 45.67B | |
| -0.67% | +0.70% | -18.23% | -8.00% | -27.43% | -38.36% | -0.85% | -7.92% | +173.04% | 42.47B | |
| Average | +0.35% | +2.20% | -0.62% | +9.07% | +8.92% | +31.14% | +42.40% | +77.52% | +179.54% | 236.79B | |
| Weighted average by Cap. | +0.29% | +2.43% | +0.04% | +8.91% | +11.21% | +34.17% | +54.73% | +138.47% | +412.34% |
- Stock Market
- Stocks
- ROVI Stock
- ROVI Stock
- Sector Laboratorios Farmaceuticos Rovi, S.A.
Select your edition
All financial news and data tailored to specific country editions
